Paul Billings

Dr. Paul R. Billings is a board-certified internist and clinical geneticist, who also holds a PhD in Immunology, from Harvard University. He worked there with Dr. Baruj Benacerraf, who subsequently received the Nobel Prize in Medicine.

In 2018, Dr. Billings became the Chief Medical Officer and Senior Vice President for Medical Affairs at Natera, Inc., a global leader in human genetic testing. Dr Billings recently has been a Partner in the diagnostic medicine consultancy, the Bethesda Group, and the Managing Director of the Bethesda Group Fund.

He is Chairman of PlumCare, LLC, and Synergenz Biosciences Limited. He has held academic and research appointments at Harvard University, UC San Francisco, Stanford University and UC Berkeley. He has published approximately 200 papers and volumes. He co-founded the stem cell company, CBR Systems, was a Director at and Signature Genomics Inc., and is co-founder and senior advisor of Fabric Genomics, Inc., a leading genome informatics firm.

Since June of 2019 he is also Chairman of the Board of OmniSeq, Inc., a cancer diagnostic company affiliated with Roswell Park Cancer Center in Buffalo, NY. He is also a Director at OmniSeq Inc., which provides novel cancer and immunodiagnostic testing. Dr. Billings advises or directs several other firms in the precision medicine field.

Until 2018, Dr. Billings was the Chairman of Biological Dynamics, a revolutionary molecular measurement platform. Dr. Billings was the SVP and Senior Physician at Laboratory Corporation of America, Inc., and Chief Medical Officer at Life Technologies Inc. (Applied Biosystems), and later the clinical division of ThermoFisher Scientific Inc. He is an expert in precision medicine diagnostics particularly in Oncology, Transplantation and Women’s Health.